In conclusion, we demonstrated that locally injected CAR T-cell adjacent to the tumor lead to intratumoral accumulation and reduced tumor growth translating into a survival benefit of EpCAM/GFPCAR T-cell-treated mice. The gene discussed is EPCAM; the disease is neoplasm.